Schonfeld Strategic Advisors LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1665241
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$999,800
-$848,463 QoQ
Shares Held
1,862
-66.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#198
of 411 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Mar 31, 2023CallValue
$237,017
CallShares
60,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. MDGL ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in MDGL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $999,800 | 1,862 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $1,848,263 | 5,580 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,704,849 | 5,525 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,782,068 | 46,094 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,852,713 | 24,460 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $2,882,532 | 12,458 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,446,971 | 71,535 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,588,815 | 19,865 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $237,017 | 60,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $7,220,317 | 29,804 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,237,650 | 14,600 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $907,500 | 50,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $812,000 | 95,300 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $4,467,152 | 68,736 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $883,798 | 12,347 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $754,609 | 8,905 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $462,782 | 5,800 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $603,942 | 6,200 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $3,562,204 | 30,454 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $772,576 | 6,507 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $892,976 | 7,885 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $528,805 | 7,921 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||